Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
3659.T Stock Summary
Top 10 Correlated ETFs
3659.T
In the News
3659.T Financial details
Company Rating
Sell
Market Cap
2003.3B
Income
70.61B
Revenue
423.36B
Book val./share
1058.52
Cash/share
704.79
Dividend
10
Dividend %
0.35%
Employees
8.23K
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
22.95
Forward P/E
-
PEG
-8.1
P/S
5.5
P/B
2.44
P/C
3.31
P/FCF
19.13
Quick Ratio
3.06
Current Ratio
7.73
Debt / Equity
0.03
LT Debt / Equity
0.03
-
-
EPS (TTM)
82.24
EPS next Y
-
EPS next Q
-
EPS this Y
-27.76%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-8.51%
Revenue last 5Y
11.24%
Revenue Q/Q
-29.67%
EPS Q/Q
-219.84%
-
-
-
-
SMA20
-6.25%
SMA50
-6.9%
SMA100
-20.36%
Inst Own
-
Inst Trans
-
ROA
9%
ROE
11%
ROC
0.13%
Gross Margin
68%
Oper. Margin
34%
Profit Margin
25%
Payout
8%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2256.0-3278.0
52W High
-28.86%
52W Low
+3.37%
RSI
38
Rel Volume
0.72
Avg Volume
3.19M
Volume
2.3M
Perf Week
-4.95%
Perf Month
-7.52%
Perf Quarter
-6.16%
Perf Half Y
-9.54%
-
-
-
-
Beta
0.228
-
-
Volatility
31.59%, 81.64%
Prev Close
-4.21%
Price
2332
Change
-3.62%
3659.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 277.93 | 331.35 | 307.96 | 404.47 | 496.99 | |
Net income per share | 129.34 | 63.57 | 128.91 | 114.74 | 82.89 | |
Operating cash flow per share | 117.49 | 155.6 | 118.84 | 148.82 | 151.1 | |
Free cash flow per share | 115.13 | 151.95 | 102.99 | 142.07 | 143.98 | |
Cash per share | 293.03 | 316.52 | 442.51 | 494.5 | 700.55 | |
Book value per share | 693.28 | 802.73 | 938.78 | 981.33 | 1.05K | |
Tangible book value per share | 634.18 | 754.33 | 885.57 | 935.09 | 991.74 | |
Share holders equity per share | 693.28 | 802.73 | 938.78 | 981.33 | 1.05K | |
Interest debt per share | 16.92 | 40.3 | 18.72 | 41.41 | 43.44 | |
Market cap | 1296.7B | 2812.19B | 1982.1B | 2590.32B | 2188.81B | |
Enterprise value | 1055.92B | 2576.21B | 1632.19B | 2204.27B | 1938.02B | |
P/E ratio | 11.21 | 50.02 | 17.25 | 25.82 | 31 | |
Price to sales ratio | 5.22 | 9.6 | 7.22 | 7.32 | 5.17 | |
POCF ratio | 12.34 | 20.44 | 18.71 | 19.9 | 17.01 | |
PFCF ratio | 12.59 | 20.93 | 21.59 | 20.85 | 17.85 | |
P/B Ratio | 2.09 | 3.96 | 2.37 | 3.02 | 2.44 | |
PTB ratio | 2.09 | 3.96 | 2.37 | 3.02 | 2.44 | |
EV to sales | 4.25 | 8.79 | 5.95 | 6.23 | 4.58 | |
Enterprise value over EBITDA | 8 | 18.97 | 11.11 | 13.32 | 13.25 | |
EV to operating cash flow | 10.05 | 18.72 | 15.41 | 16.94 | 15.06 | |
EV to free cash flow | 10.26 | 19.17 | 17.78 | 17.74 | 15.8 | |
Earnings yield | 0.09 | 0.02 | 0.06 | 0.04 | 0.03 | |
Free cash flow yield | 0.08 | 0.05 | 0.05 | 0.05 | 0.06 | |
Debt to equity | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | |
Debt to assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | |
Net debt to EBITDA | -1.82 | -1.74 | -2.38 | -2.33 | -1.71 | |
Current ratio | 13.44 | 9.98 | 11.13 | 7.72 | 7.71 | |
Interest coverage | 41.6 | 5.85 | 102.15 | 12.32 | 18.91 | |
Income quality | 0.86 | 1.27 | 0.78 | 0.93 | 1.82 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.02 | 0.08 | 0.04 | 0.09 | 0.12 | |
Sales general and administrative to revenue | 0.34 | 0.35 | 0.4 | 0.39 | 0.35 | |
Research and developement to revenue | 0.06 | 0.06 | 0.08 | 0.07 | 0.06 | |
Intangibles to total assets | 0.09 | 0.06 | 0.06 | 0.05 | 0.06 | |
Capex to operating cash flow | -0.02 | -0.02 | -0.13 | -0.05 | -0.05 | |
Capex to revenue | -0.01 | -0.01 | -0.05 | -0.02 | -0.01 | |
Capex to depreciation | -0.27 | -0.38 | -1.67 | -0.87 | -0.71 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.04 | 0.03 | 0.01 | |
Graham number | 1.42K | 1.07K | 1.65K | 1.59K | 1.4K | |
ROIC | 0.14 | 0.08 | 0.13 | 0.12 | 0.08 | |
Return on tangible assets | 0.18 | 0.07 | 0.12 | 0.1 | 0.07 | |
Graham Net | 362.58 | 328.45 | 394.59 | 413.05 | 509.06 | |
Working capital | 512.33B | 520.57B | 540.39B | 558.9B | 600.13B | |
Tangible asset value | 567.13B | 667.09B | 789.25B | 817.76B | 844.8B | |
Net current asset value | 465.54B | 436.82B | 452.98B | 466.73B | 497.98B | |
Invested capital | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | |
Average receivables | 14.32B | 24.79B | 19.26B | 24.01B | 34.16B | |
Average payables | 7.6B | 9.21B | 10.01B | 12.03B | 10.34B | |
Average inventory | 128.67B | 265.23B | 221.41B | 166.09B | 81.25B | |
Days sales outstanding | 42.06 | 26.08 | 23.38 | 31.42 | 32.65 | |
Days payables outstanding | 47.49 | 56.42 | 47.34 | 50.74 | 15.35 | |
Days of inventory on hand | 1.58K | 1.44K | 858.79 | 560.69 | 0 | |
Receivables turnover | 8.68 | 14 | 15.61 | 11.62 | 11.18 | |
Payables turnover | 7.69 | 6.47 | 7.71 | 7.19 | 23.78 | |
Inventory turnover | 0.23 | 0.25 | 0.43 | 0.65 | 0 | |
ROE | 0.19 | 0.08 | 0.14 | 0.12 | 0.08 | |
Capex per share | -2.37 | -3.65 | -15.85 | -6.75 | -7.12 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 93.85 | 144.87 | 110.83 | 141.14 | 99.89 | |
Net income per share | -8.99 | 61.63 | 28.8 | 41.28 | -49.47 | |
Operating cash flow per share | 31.22 | 33.31 | 34.19 | 48.24 | 35.37 | |
Free cash flow per share | 30.15 | 31.24 | 32.37 | 47.24 | 33.49 | |
Cash per share | 500.49 | 368.45 | 341.79 | 333.39 | 704.79 | |
Book value per share | 993.22 | 1.01K | 1.13K | 1.16K | 1.06K | |
Tangible book value per share | 946.42 | 958.52 | 1.07K | 1.1K | 997.74 | |
Share holders equity per share | 993.22 | 1.01K | 1.13K | 1.16K | 1.06K | |
Interest debt per share | 32.89 | 30.31 | 31.97 | 44.28 | 36.56 | |
Market cap | 2559.32B | 2702.47B | 2340.62B | 2277.84B | 2175.63B | |
Enterprise value | 2173.28B | 2436.35B | 2105.53B | 2059.1B | 1924.84B | |
P/E ratio | -82.35 | 12.8 | 23.85 | 16.19 | -12.99 | |
Price to sales ratio | 31.56 | 21.78 | 24.79 | 18.94 | 25.72 | |
POCF ratio | 94.86 | 94.71 | 80.35 | 55.42 | 72.65 | |
PFCF ratio | 98.26 | 101 | 84.87 | 56.59 | 76.73 | |
P/B Ratio | 2.98 | 3.12 | 2.44 | 2.31 | 2.43 | |
PTB ratio | 2.98 | 3.12 | 2.44 | 2.31 | 2.43 | |
EV to sales | 26.8 | 19.63 | 22.3 | 17.12 | 22.76 | |
Enterprise value over EBITDA | -247.44 | 34.14 | 46.55 | 33.25 | 212.5 | |
EV to operating cash flow | 80.55 | 85.39 | 72.28 | 50.1 | 64.27 | |
EV to free cash flow | 83.44 | 91.05 | 76.35 | 51.16 | 67.88 | |
Earnings yield | 0 | 0.02 | 0.01 | 0.02 | -0.02 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | |
Debt to equity | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Debt to assets | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | |
Net debt to EBITDA | 43.95 | -3.73 | -5.2 | -3.53 | -27.69 | |
Current ratio | 7.72 | 6.57 | 8.33 | 7.73 | 7.71 | |
Interest coverage | 2.15 | 133.35 | 85.76 | 7.36 | 5.44 | |
Income quality | -1.65 | 0.4 | 0.68 | 0.78 | -0.71 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0.08 | 0 | 0.12 | 0 | |
Sales general and administrative to revenue | 0.47 | 0.26 | 0.36 | 0.31 | 0.51 | |
Research and developement to revenue | 0.09 | 0.05 | 0.06 | 0.05 | 0.08 | |
Intangibles to total assets | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | |
Capex to operating cash flow | -0.03 | -0.06 | -0.05 | -0.02 | -0.05 | |
Capex to revenue | -0.01 | -0.01 | -0.02 | -0.01 | -0.02 | |
Capex to depreciation | -0.58 | -1.01 | -0.61 | -0.43 | -0.68 | |
Stock based compensation to revenue | 0.02 | 0 | 0.02 | 0.01 | 0.01 | |
Graham number | 448.29 | 1.18K | 854.11 | 1.04K | 1.09K | |
ROIC | 0.01 | 0.05 | 0.02 | 0.03 | 0.01 | |
Return on tangible assets | -0.01 | 0.05 | 0.02 | 0.03 | -0.04 | |
Graham Net | 418.05 | 342.35 | 353.78 | 360.3 | 512.14 | |
Working capital | 558.9B | 539.19B | 593.81B | 624.66B | 600.13B | |
Tangible asset value | 817.76B | 821.04B | 911.71B | 938.06B | 844.8B | |
Net current asset value | 466.73B | 446.14B | 492.43B | 519.84B | 497.98B | |
Invested capital | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Average receivables | 32.03B | 46.07B | 50.96B | 44.27B | 43.09B | |
Average payables | 13.7B | 15B | 14.17B | 14.09B | 15.73B | |
Average inventory | 140B | 202.41B | 283.55B | 346.71B | 184.32B | |
Days sales outstanding | 33.79 | 44.74 | 38.34 | 36.16 | 40.3 | |
Days payables outstanding | 43.03 | 40.19 | 35.83 | 37.89 | 42 | |
Days of inventory on hand | 475.47 | 637.08 | 891.04 | 923.98 | 0 | |
Receivables turnover | 2.66 | 2.01 | 2.35 | 2.49 | 2.23 | |
Payables turnover | 2.09 | 2.24 | 2.51 | 2.38 | 2.14 | |
Inventory turnover | 0.19 | 0.14 | 0.1 | 0.1 | 0 | |
ROE | -0.01 | 0.06 | 0.03 | 0.04 | -0.05 | |
Capex per share | -1.08 | -2.07 | -1.82 | -1 | -1.88 |
3659.T Frequently Asked Questions
What is NEXON Co., Ltd. stock symbol ?
NEXON Co., Ltd. is a JP stock and trading under the symbol 3659.T
What is NEXON Co., Ltd. stock quote today ?
NEXON Co., Ltd. stock price is $2332 today.
Is NEXON Co., Ltd. stock public?
Yes, NEXON Co., Ltd. is a publicly traded company.